摘要
Continuous renal replacement therapy (CRRT) is widely used for treating critically-ill patients in the emergency department in China. Anticoagulant therapy is needed to prevent clotting in the extracorporeal circulation during CRRT. Regional citrate anticoagulation (RCA) has been shown to potentially be safer and more effective and is now recommended as the preferred anticoagulant method for CRRT. However, there is still a lack of unified standards for RCA management in the world, and there are many problems in using this method in clinical practice. The Emergency Medical Doctor Branch of the Chinese Medical Doctor Association (CMDA) organized a panel of domestic emergency medicine experts and international experts of CRRT to discuss RCA-related issues, including the advantages and disadvantages of RCA in CRRT anticoagulation, the principle of RCA, parameter settings for RCA, monitoring of RCA (mainly metabolic acid-base disorders), and special issues during RCA. Based on the latest available research evidence as well as the paneled experts' clinical experience, considering the generalizability, suitability, and potential resource utilization, while also balancing clinical advantages and disadvantages, a total of 16 guideline recommendations were formed from the experts' consensus.
学科与关键词
- Determinants of Calcium Infusion Rate During Continuous Veno-venous Hemofiltration with Regional Citrate Anticoagulation in Critically Ill Patients with Acute Kidney InjuryWen Xiong, Li; De Lin, Liu; Li Feng, Huang; Wen Liang, Ma; Qi, Ding; Yue, Han; Yue, ZhengChinese Medical Journal, 2016, 129(14): 1682.
- Continuous Renal-Replacement Therapy in Critically Ill Children: Practice Changes and Association With OutcomeChen, ZhiJiang; Wang, HuiLi; Wu, Zhu; Jin, Ming; Chen, YiTing; Li, Jun; Wei, QiuJu; Tao, ShaoHua*; Zeng, Qiyi*Pediatric Critical Care Medicine, 2021, 22(12): E605-E612.被引 4
- Plasma Metformin Levels at Almost 24 Hours Would Help With the Delicate Decision to Start Renal Replacement Therapy: We Disagree as Lactate That Is More Widely and Early Available Should Be a Much Better Trigger to Start Renal Replacement Therapy!Patrick M., Honore; Sebastien, Redant; Keitiane, Kaefer; Luc, Kugener; Leonel, Barreto Gutierrez; Rachid, Attou; Andrea, Gallerani; David, De BelsCritical Care Medicine, 2021, 49(4): e463-e464.
